top of page
Search

Concenter Biopharma Ltd. is developing a Promising Drug for Treating and Preventing Type 2 Diabetes

  • Concenter BioPharma
  • Nov 29, 2019
  • 1 min read

Updated: Dec 8, 2020


Team Concenter Bio Pharma
Concenter Bio Pharma - Fucused on People & Therapies

Concenter Biopharma is working on a novel drug to eliminate type 2 diabetes with no side effects. The drug dramatically lowers insulin resistance, the major cause of T2D, while lowering the body’s chronic and systemic inflammation levels.





Comments

Logo concenter biopharma.jpg

Hi, thanks for stopping by!

Concenter BioPharma is a subsidiary of Silkim Pharma Ltd., which developed a novel, protected PLATFORM of drugs for proven treatments of multiple indications. 

 

Our PLATFORM is the result of extensive investigation of animal models of human diseases.

Let the news
come to you.

Thanks for submitting!

  • LinkedIn
  • Facebook
  • Twitter
bottom of page